Venom Inc Arrives in the Marvel Universe


Marvel sent over this preview of the upcoming Venom Inc storyline.

Ryan Stegman, Dan Slott and Mike Costa lead the six-issue crossover starting in December

 

New York, NY—September 15, 2017—Venom is sweeping across the Marvel Universe, and in an epic new crossover, Eddie Brock finally makes his way into Spider-Man’s world with VENOM INC. Announced exclusively on Marvel’s weekly podcast This Week In Marvel, the six-part story kicks off in VENOM INC/ALPHA #1, written by superstar writers Dan Slott and Mike Costa, with art by Ryan Stegman.

 

“We’re in a bit of a Venom renaissance—a Ven-aissance?—of late, and I got real excited when I not only heard about Venom Inc., but that we’d get to announce it on This Week in Marvel!” said Ryan Penagos, Vice President and Executive Editor of Marvel Digital Media. “If you haven’t listened to any of the 300+ episodes of This Week in Marvel yet, I hope you come for the news we’ll continue to break going forward, and stay for the interviews, in-depth look at all the amazing Marvel Comics out each week, great community, and more.”

 

Following ALPHA #1, the story continues in AMAZING SPIDER-MAN and VENOM. At the heart of the story? The relationship between fan favorites Peter Parker and Eddie Brock…who haven’t been face-to-face in years. Add in Flash Thompson, and this is one reunion you’re not going to want to miss.

 

“Flash Thompson] got to be that hero when he was Venom….but that was everything he’d wanted. And now it’s gone. It was robbed from him. And so, he’s trying to figure out what his role in life is…and where that story goes, I’m not gonna tell you,” teased Executive Editor Nick Lowe.

 

What can be said about VENOM INC? “You don’t get much more LEGACY than this story,” promised Lowe. “Twists! Turns! Classic Spider-Man characters, but all treading on new ground! And to have Ryan Stegman returning to AMAZING SPIDER-MAN? I’m embarrassed by the creative riches here!”

 

With classic Spider-Man characters, new villains, infamous Venom symbiote, and blockbuster storytelling by both the SPIDER-MAN and VENOMVERSE teams, VENOM INC promises to rock the world of our favorite Wall-Crawler. Don’t miss the most adventurous crossover yet – VENOM/ALPHA #1 hits comics shops on December 6th!

 

You can listen to the exclusive announcement on This Week In Marvel on Marvel.com, as well as on Soundcloud and iTunes.

 

 

 

VENOM INC/ALPHA #1: VENOM INC PART 1

Written by DAN SLOTT & MIKE COSTA

Art by RYAN STEGMAN

 

AMAZING SPIDER-MAN #972: VENOM INC PART 2

Written by DAN SLOTT

Art by RYAN STEGMAN

 

VENOM #159: VENOM INC PART 3

Written by MIKE COSTA

Art by GERARDO SANDOVAL

 

AMAZING SPIDER-MAN #793 PART 4

Written by DAN SLOTT

Art by RYAN STEGMAN

Liked it? Take a second to support the Crawlspace on Patreon!

(5) Comments

  1. Al

    Pros Ryan Stegman art Cons Slott involvment. Mentioning Peter as a 'fan favourite' and like basically doing VenomVerse 2.0 by ripping off another Spider-Man story idea...except with Venom

  2. John Simons

    I'm so excited for this. I'll probably really enjoy the Costa side of this and be crushingly disappointed by the Slott side. I hope I'm wrong. In any case though, we'll get to see Brock and Parker together in an ASM story for the first time since the Mackie/Byrne days (AND a Crawlspace review team-up between Alford, Bogenreider, and Martineau maybe?!)

  3. Victor

    @Mark Alford DC has had some success with this formula of smaller events contained to just a couple of titles since Rebirth, so I guess Marvel is jumping on that same train. However, DC did give their titles a little more time to breath and establish their own status quo before crossing over.

  4. WolfCypher

    Pros - An interesting use if Black Cat, her syndicate, the Venom symbiote clone, and Lee Price. A chance to see Spider-Man and this current Venom (an Eddie Brock with real character and proper directio ) interact. Cons - Dan Slott. Cons - Dan Slott ruins everything he touches. Cons - Dan Slott.

Leave a Reply

Your email address will not be published. Required fields are marked *